The American Urological Association (AUA) continues to be a leader in developing innovative, evidence-based quality education for urologists and urologic health care professionals worldwide
Congress
The American Urological Association (AUA) Congress 2023
The American Urological Association (AUA) Congress from April 28th - May 1st 2023, in Chicago, USA
-
Event type:Congress
-
Date28 Mar 2023 - 1 May 2023
-
Location
Through the Annual Meeting—and other year-round educational offerings the AUA sets the highest standards for urologic education.
Join urologists around the globe at the 2023 AUA Annual Meeting in Chicago. The Annual Meeting, in its 118th year, is the largest gathering of urologists in the world, providing unparalleled access to groundbreaking research, new guidelines and the latest advances in urologic medicine. With all the AUA has to offer, it's no wonder Annual Meeting attendees repeatedly report that the knowledge they take from the meeting positively impacts their practices.
Who Should Attend?
The AUA Annual Meeting offers the latest technology and urologic education for:
- Urologists
- Oncologists
- Doctors of Osteopathy
- Urology Residents
- Researchers
- Advanced Practice Professionals (Physician Assistants, Nurse Practitioners)
- Educators
- Technicians
- Nurses
- Medical Assistants
- Medical Students
- Health Care Professionals
More content available within our dedicated Learning Zones and Speciality Hubs
Urology
Learning materials and guidelines on Urology.
Transplantation Learning Zone
Welcome to the Transplantation Learning Zone, an online resource intended to educate healthcare professionals in best practice for the transplantation of various organs.
Chronic Kidney Disease Learning Zone
Chronic Kidney Disease (CKD) is a disease that can often lead to a need for haemodialysis and kidney transplantation. New CKD treatments are emerging which focus on delaying CKD disease progression and the need for transplantation.
Oncology
A detailed look at conditions connected to Oncology.
CDK4/6 inhibitors in breast cancer
Are you familiar with the clinical trial evidence that could help you to select the best cyclin dependent kinase 4/6 (CDK4/6) inhibitor for your metastatic breast cancer patient?